Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Vascular endothelial growth factor receptor 2' and Ligand = 'BDBM316135'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Vascular endothelial growth factor receptor 2 (Homo sapiens (Human))	BDBM316135 (2-{[3-({4-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl...) Show SMILES CNC(=O)c1ccccc1Sc1ccc2c(n[nH]c2c1)C#Cc1ccc(NC(=O)NCCOCCOCCOCCOCCOC)cc1 Show InChI InChI=1S/C35H41N5O7S/c1-36-34(41)30-5-3-4-6-33(30)48-28-12-13-29-31(39-40-32(29)25-28)14-9-26-7-10-27(11-8-26)38-35(42)37-15-16-44-19-20-46-23-24-47-22-21-45-18-17-43-2/h3-8,10-13,25H,15-24H2,1-2H3,(H,36,41)(H,39,40)(H2,37,38,42)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.90	n/a	n/a	n/a	n/a	n/a	n/a
SENJU PHARMACEUTICAL CO., LTD. US Patent					Assay Description Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...				US Patent US9617222 (2017) BindingDB Entry DOI: 10.7270/Q2FN189X
					More data for this Ligand-Target Pair